The company also said the US drug watchdog, which inspected a formulations manufacturing facility of its wholly owned subsidiary Eugia Pharma Specialties Ltd at Bhiwadi in Alwar, Rajasthan, between April 25 to May 3 this year, has classified the inspection as official action indicated (OAI).
News
Aurobindo gets USFDA nod for generic version of Novo Nordisk’s Vagifem
August 9, 2024
The company also said the US drug watchdog, which inspected a formulations manufacturing facility of its wholly owned subsidiary Eugia Pharma Specialties Ltd at Bhiwadi in Alwar, Rajasthan, between April 25 to May 3 this year, has classified the inspection as official action indicated (OAI).